AZITRA, INC. (AZTR)

(10% Negative) AZITRA, INC. (AZTR) Announces Delay in results Trials for ex vivo human skin Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment